Elon Musk Wins Reinstatement of Historic Tesla Pay Package After Delaware Supreme Court Ruling 
Roche CEO Warns US Drug Price Deals Could Raise Costs of New Medicines in Switzerland 
FedEx Beats Q2 Earnings Expectations, Raises Full-Year Outlook Despite Stock Dip 
Nike Shares Slide as Margins Fall Again Amid China Slump and Costly Turnaround 
Oracle Stock Surges After Hours on TikTok Deal Optimism and OpenAI Fundraising Buzz 
U.S. Lawmakers Urge Pentagon to Blacklist More Chinese Tech Firms Over Military Ties 
7-Eleven CEO Joe DePinto to Retire After Two Decades at the Helm 
Union-Aligned Investors Question Amazon, Walmart and Alphabet on Trump Immigration Policies 
Apple Opens iPhone to Alternative App Stores in Japan Under New Competition Law 
Oracle Stock Slides After Blue Owl Exit Report, Company Says Michigan Data Center Talks Remain on Track 
Dina Powell McCormick Resigns From Meta Board After Eight Months, May Take Advisory Role 
Micron Technology Forecasts Surge in Revenue and Earnings on AI-Driven Memory Demand 
Toyota to Sell U.S.-Made Camry, Highlander, and Tundra in Japan From 2026 to Ease Trade Tensions 
Trump Signals Push for Lower Health Insurance Prices as ACA Premium Concerns Grow 
Instacart Stock Drops After FTC Probes AI-Based Price Discrimination Claims 
Maersk Vessel Successfully Transits Red Sea After Nearly Two Years Amid Ongoing Security Concerns 
TikTok U.S. Deal Advances as ByteDance Signs Binding Joint Venture Agreement 
MORRISVILLE, N.C., Aug. 03, 2017 -- Clinipace Worldwide, a global full-service clinical research organization (CRO), has launched a new regulatory and strategic development consultancy called RSD Global Consulting (RSDGC).
With more than 50 specialists, Clinipace RSD Global Consulting provides strategic consulting and regulatory support in the United States, Europe, and Asia Pacific. RSDGC offers stage-specific solutions for all phases of development, from non-clinical and clinical, through to marketing applications and post-marketing support. The group also provides all aspects of pharmaceutical development support, including chemistry, manufacturing, and controls (CMC) strategy; dossier preparation ; pre-approval inspection (PAI) preparation; GxP auditing for compliance in pre-clinical (GLP), clinical (GCP), manufacturing (GMP), medical/regulatory writing, strategic biostatistics and a quality assurance (QA) consultancy.
“Whatever the scale or complexity, RSD Global Consulting has the breadth and depth of technical, regulatory and quality expertise to take promising therapies from bench to bedside,” said Nikolas Burlew, who was recently appointed as Executive Vice President of RSD Global Consulting. “Our RSD Global Consulting team applies pragmatic approaches to the complex challenges of drug development, managing costs, quality, and deliverables to ensure that our clients’ goals are met.”
“We are delighted to launch this new consultancy in response to customer demand, especially amongst the early state biotech and pharma companies that we serve” said Clinipace President and CEO Jeff Williams. “We can work with companies of all sizes, from early-stage biotech firms, through to clinical stage and multinational. From traditional small molecules to advanced biologics, across the complete array of dosage forms and a wide range of therapeutic areas, we can help customers plan and advance their programs into the clinic, to regulatory approval and beyond.”
About Clinipace Worldwide
Clinipace Worldwide, a global full-service clinical research organization (CRO) serves the unique needs of venture-backed, mid-tier and strategic pharmaceutical, biotechnology and medical device firms, helping them advance drug candidates to deliver successful stakeholder and patient outcomes.
The company leverages extensive therapeutic knowledge, clinical trial expertise, and their proprietary eClinical platform TEMPO™ to support life science firms in achieving some of their most important goals: Executing regulatory strategies, optimizing clinical development timelines and completing high quality trials. Clinipace has completed more than 1,500 clinical trials and 1,500 regulatory and statistical consulting projects and operates in North America, South American, Europe, and Asia. To learn more, visit www.clinipace.com.
Media Contact Sandra Parrish Woodlief 919-797-9480; [email protected]
